The PLET-Study: Autologous platelet-leukocyte rich plasma treatment in lateral elbow tendinopathy to speed up healing and shorten the return to activity time.

The PLET-Study: Autologous platelet-leukocyte rich plasma treatment in lateral elbow tendinopathy to speed up healing and shorten the return to activity time. - Lateral elbow tendinopathy and P-LRP treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33398

Enrollment

126

Registered

2009-08-17

Start date

2010-08-02

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral elbow tendinopathy tenniselbow

Interventions

Ultrasound guided injection of platelet-leucocyte rich plasma in lateral elbow tendinopathy.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Clinical diagnosis of lateral elbow tendinopathy (see also page 16 of protocol). Established diagnosis of 3 months.

Exclusion criteria

Exclusion criteria: Tendonruptures History of elbowoperation Other explanations for pain lateral elbow (i.e. arthrosis)

Design outcomes

Primary

Measure	Time frame
Earlier return to activities, confirmed by Nirschl-classification and DASH-scores.	—

Secondary

Measure	Time frame
Pain assessment, patient satisfaction, recurrence rates and ultrasound control.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)